Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Merck sells corticotropin NDAs to ANI for $75mm

Executive Summary

Merck & Co. Inc. sold two corticotropin NDAs to ANI Pharmaceuticals Inc. for $75mm. The NDAs cover purified corticoptropin gel (40 units/mL and 80 units/mL) and corticotropin zinc hydrozide (40 units/mL).
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase
    • Reverse Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register